Repligen beefs up cell therapy business with $1.5 billion deal for BioLife
Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at about $1.5 billion, to expand the drugmaking equipment provider's
July 22, 2026
NTSB still searching for answers in fiery medevac jet crash in Philadelphia neighborhood last year
Crews work to restore power to thousands after Lala raked Hawaii
In Meta's trial, families of social media victims see a pivotal moment for online safety
Trump pushes for Kim Jong Un meeting this year, WSJ reports
Boy surprised with trip to Disney World during Wish Day
'Dream within a dream' for pass rusher Von Miller to join his hometown Dallas Cowboys